Blood test could signal safe time to halt cancer treatment
NCT ID NCT06146920
Summary
This study is testing if a simple blood test can help doctors decide when it might be safe for some cancer patients to stop their immunotherapy. It involves 39 people with advanced melanoma or non-small cell lung cancer whose cancer is under control after at least a year of treatment. The main goal is to see if patients with no cancer DNA detected in their blood can safely stop therapy without their cancer returning within a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.